All lobbying filings

THE MCMANUS GROUP

Lobbying for INFUSION PROVIDERS ALLIANCE · Association representing infusion drug providers.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Delaware · House · Senate · $90,000.00 income · posted Jul 21, 2025

Official filing document

Bills named in this filing 2

HR 879
Medicare Patient Access and Practice Stabilization Act of 2025
HR 4299
Protecting Patient Access to Cancer and Complex Therapies Act

Lobbying activity 2

Medicare/Medicaid

Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to physician reimbursement for Part B drugs. Issues related to virtual supervision of infusion drugs. H.R. 879 Medicare Patient Access and Practice Stabilization Act Issues related to physician reimbursement to complex drug administration. Issues related to appropriate reimbursement for administration of Part B drugs. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act

Health Issues

Advocating for access to and reimbursement for biosimilars. Issues related to patient access to infusion products for asthma and allergies.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.